Cargando…
Sofosbuvir for the treatment of chronic hepatitis C: between current evidence and future perspectives
In recent years, clinical research in the field of new treatments for chronic hepatitis C (HCV) has been devoted to developing regimens based on direct-acting antivirals (DAAs), with the goal of increasing treatment efficacy and improving tolerability and safety. This can be achieved by Peginterfero...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4010630/ https://www.ncbi.nlm.nih.gov/pubmed/24822024 http://dx.doi.org/10.2147/HMER.S44375 |